Zolimidine

Zolimidine, a derivate of imidazopyridine, is an orally active antiulcer agent. Zolimidine stimulates mucus secretion in intestinal mucosal cells and enhacnes intestinal wall more resistant to ulceration. Zolimidine exhibits gastroprotective effect in duodenal ulcer research[1][2].

Product Specifications

CAS Number

[1222-57-7]

UNSPSC

12352005

Hazard Statement

H310-H317-H319-H410

Target

Drug Derivative

Type

Reference compound

Related Pathways

Others

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Endocrinology

Assay Protocol

https://www.medchemexpress.com/zolimidine.html

Purity

99.65

Solubility

DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

O=S(C1=CC=C(C2=CN3C=CC=CC3=N2)C=C1)(C)=O

Molecular Formula

C14H12N2O2S

Molecular Weight

272.32

Precautions

P261-P262-P264-P270-P272-P273-P280-P302+P352-P305+P351+P338-P361+P364-P362+P364-P391-P405-P501

References & Citations

[1]Belohlavek D, et al. The effect of zolimidine, imidazopyridine-derivate, on the duodenal ulcer healing. Scand J Gastroenterol Suppl. 1979;54:44. |[2]Carminati GM, et al. Protective action of zolimidine against two different types of experimental intestinal ulcers. Farmaco, Edizione Pratica (1978), 33 (2), 68-79.